Message from the president & CEO

Welcome to the Miraculins Inc. web site.

Cancer is the most complex of all diseases. While there is a significant focus on the development of new and improved cancer therapeutics, evidence strongly indicates that the early detection of cancer is equally important. Early detection through diagnostic testing can dramatically improve one's chances not only of extended survival, but of a complete cure.

Miraculins is one of many research and development companies around the world working in the area of molecular diagnostics. Our proteomic-based biomarker research is focused on discovering and validating subtle changes in an individual's protein chemistry as a result of the onset of disease. These subtle differences can be identified, monitored and subsequently developed into key diagnostics. Armed with improved diagnostic tools, the medical community will be better equipped to provide prompt, accurate diagnoses and deliver treatment at the earliest possible stage of the disease.

Miraculins is dedicated to helping save lives through its many research and development programs, as well as delivering value to our shareholders by building a world-class biotechnology company.

Thank you for taking the time to visit our web site to learn more about Miraculins. The site contains a wealth of information, so please be sure to visit all areas to gain a thorough knowledge of who we are and what we do.

Sincerely,  

Christopher J. Moreau
President and CEO, Miraculins Inc.

March 2007